作者: Prasad S Kulkarni , Sharad Agarkhedkar , Sanjay Lalwani , Ashish R Bavdekar , Sameer Jog
DOI: 10.4161/HV.27490
关键词:
摘要: A live attenuated influenza A(H1N1)pdm 2009 vaccine was developed and distributed in India 2010. We estimated the effectiveness (VE) against laboratory-confirmed pandemic H1N1 (pH1N1) infections patients with influenza-like illness who visited five tertiary care hospitals Pune, during June–December Swab specimens were analyzed for pH1N1 by reverse transcriptase polymerase chain reaction (RT-PCR). VE using test-negative case-control study design logistic regression. total of 784 (253 cases, 531 controls) analyzed. The unadjusted overall 75.5% (95% confidence interval [CI] 42.1–89.7), while adjusted 76% CI 42.1–89.7). conclude that effective our population, which has opened prospects this platform trivalent formulations.